profit from every CA$100 of sales.
CA$0CA$100
Curaleaf Holdings
CA$11.21-5.40% today
-7.0% in 1 year
1-year low CA$7.921-year high CA$19.47
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Curaleaf Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from CA$100 of sales | Sales growth a year | Price per CA$1 of profit |
|---|---|---|---|
| Curaleaf Holdings | No profit yet | ||
 Merck KGaA | 24.9× · Fair price | ||
 Takeda Pharmaceutical | 102.5× · Very expensive | ||
 Galderma Group | 86.9× · Very expensive | ||
 Teva Pharmaceutical Industries | 36.8× · Expensive |
AI analysis
An AI analyst reads Curaleaf Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- 5.1×
- 1.6×
- 28.5×
- –
- 3.5%
- -13.1%
- –
Profitability
- 49.8%
- 2.0%
- -21.6%
- –
- 1.0%
- -0.1%
- –
- –
- –
- –
Growth
- −0.2%
- –
- –
- –
- +3.5%
Financial health
- 3.1×
- 1.09
- –
- 0.2×
- 1.52
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 32%of 964
Bottom 26%of 898
Bottom 16%of 911
Top 34%of 991
News
Curaleaf challenge to Aurora Cannabis at-the-market program failsSeeking Alpha · Oct 26, 2026The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.Yahoo Finance · Aug 23, 2026Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?Yahoo Finance · Aug 20, 2026Curaleaf’s Hostile Bid For Aurora Is OfficialYahoo Finance · Aug 18, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
18No pass
Benjamin Graham
21No pass
Philip Fisher
24No pass
Peter Lynch
18No pass
Joel Greenblatt
0No pass
Charlie Munger
14No pass
Terry Smith
12No pass
Questions about Curaleaf Holdings
Is Curaleaf Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Curaleaf Holdings AI analysis
What does Curaleaf Holdings do?
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It is in Drug Manufacturers - Specialty & Generic.
Is Curaleaf Holdings stock halal?
No. Curaleaf Holdings does not pass our halal screen: its debt is 40% of its market value, at or above the 33% limit. How we check
How has Curaleaf Holdings stock done over the past year?
Down 7.0% over the past twelve months, to CA$11.21. It traded between CA$7.92 and CA$19.47 and is 42.4% below its high.
Who are Curaleaf Holdings's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Curaleaf Holdings's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.